Hostess Brands
Total Consideration
$5.40B
Share price: $34.25
Purchase-Price Allocation
Goodwill
$2.45B
Intangibles
$3.04B
Assets Acquired
$6.47B
Liabilities Assumed
$971.6M
Deferred Tax Liability
$639.4M
THE J. M. SMUCKER COMPANY — Key Metrics
3 years of history · ending 2025-04-30 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
M-Score (Beneish; >-1.78 flags risk)
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
52-Week Range
Trailing Returns
ROIC vs WACC
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
—
Book Value Per Share
—
Free Cash Flow Per Share
—
Cash Per Share
—
Revenue Per Share
—
OCF Per Share
—
Return on Equity
-17.9%
Return on Assets
-6.5%
Return on Invested Capital
-3.7%
Debt to Equity
1.16
Current Ratio
0.81
Quick Ratio
0.35
Asset Turnover
0.46
Days Sales Outstanding
25.89
Days Payables Outstanding
88.06
Days Inventory On Hand
82.64
Cash Conversion Cycle
20.47
R&D / Revenue
—
SBC / Revenue
0.3%
Capex / Revenue
4.5%
Working Capital
$-505M
Net Current Asset Value
$-9.33B
Invested Capital
$13.12B
OCF / Net Income
-0.98
FCF / Net Income
-0.66
Accruals Ratio (Sloan)
-13.9%
Net Debt
$7.68B
Net Debt / EBITDA
-19.65
Interest Coverage
1.73
Cash Coverage
-3.11
Dividend Coverage
2.66
Capex Coverage
3.07
Tangible Common Equity
$-5.97B
TCE / Total Assets
-34.0%
Goodwill / Total Assets
32.5%
NOPAT
$-532M
Cash ROIC
5.7%
WC / Revenue
-5.8%
Capex / D&A
1.39
Reinvestment Rate
-16.4%
Total Payout Ratio
-37.3%
Asset Growth vs Revenue Growth
-20.1%
Revenue 5Y CAGR
2.3%
EPS 5Y CAGR
7.7%
FCF 5Y CAGR
-3.7%
EBITDA 5Y CAGR
6.4%
Book Value 5Y CAGR
-5.8%
Stock Price (FY-end)
$112
Market Cap
—
P/E Ratio
—
P/S Ratio
—
P/B Ratio
—
P/OCF Ratio
—
P/FCF Ratio
—
Enterprise Value
—
EV / EBITDA
—
EV / Sales
—
EV / FCF
—
FCF Yield
—
Dividend Yield
—
Shareholder Yield
—
Buyback Yield
—
R&D Yield
—
Capex Yield
—
Dividend Per Share
—
DPS YoY Growth
—
Operating Leverage
-177.42
Graham Number
—
Shares Variation (YoY)
—
Beta (5Y)
0.23
Cost of Equity
5.6%
Cost of Debt (after tax)
-4.0%
WACC
—
ROIC - WACC Spread
—
52W High
$115
52W Low
$96
Trailing Return 1Y
6.4%
Trailing Return 5Y
15.7%
F-Score (Piotroski)
5.00
M-Score (Beneish)
-3.34
Z-Score (Altman)
—
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Revenue — Consensus vs Actual
Stock Price on Earnings Dates
THE J. M. SMUCKER COMPANY — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | 3.30% | 2.90% | 2.60% | -1.58% | 2.90% | 4.20% |
| Foreign Rate Differential | — | — | — | — | — | — |
| Other Adjustments | -0.20% | -0.20% | -0.50% | 20.70% | 0.10% | -0.70% |
| Qualified Production Activities (Legacy DPAD) | 0.00% | — | — | — | — | — |
| Effective Tax Rate | 24.10% | 25.20% | 25.10% | -8.92% | 25.30% | -17.60% |
Cash vs Accrual
| Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | $247.2M | $295.6M | $212.1M | $82.1M | $252.4M | $184.0M |
| Income Taxes Paid (Cash) | $227.1M | $333.2M | $233.0M | $254.8M | $316.5M | $332.1M |
THE J. M. SMUCKER COMPANY — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.
THE J. M. SMUCKER COMPANY — RestructuringNEW
Per-category restructuring disclosures sourced from us-gaap:RestructuringCostAndReserveAxis dimensional XBRL. Negative charges indicate reversals of prior accruals (a sign the original estimate was too aggressive — flattering current-period earnings).
As of 2025-04-30
| Category | Class | P&L Charge | Cash Paid | Reserve Balance |
|---|---|---|---|---|
| Employee Severance | Employee Severance | +$10M | — | $6M |
| Other Restructuring | Other | +$7M | — | — |
| Transaction Costs | Other | — | — | — |